GlassScriptPhysician profile
Phillip M King
NPI 1710961552
$9,398.44
in general payments reported to CMS, 2019-2025
42 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $329 · 2021: $1,050 · 2022: $1,568 · 2023: $2,570 · 2024: $1,756 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,515.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,956.69 | 2019-2025 | |
| Amgen INC. | $915.92 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $885.92 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $835.43 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $693.33 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $679.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $649.77 | 2019-2025 | |
| Abbott Laboratories | $408.26 | 2022-2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $299.00 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $298.71 | 2022-2024 | |
| Mylan Specialty L.P. | $211.11 | 2021-2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $195.29 | 2022-2025 | Eliquis, Camzyos |
| Allergan, INC. | $173.14 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $166.16 | 2023 | Quviviq |
| Dexcom, INC. | $110.29 | 2021-2025 | Dexcom G6 Transmitter |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.